Incyte (INCY) Ownership

INCY$122.30+2.00 +1.66%
BiotechnologyLarge CapHigh Quality
Compare
Market cap$24.93BEnterprise value$21.80BRevenue (TTM)$6.01BMarket positionTop 25%

Score

51
Neutral
Value
37
Quality
73
Growth
42

Ownership data loads after the page opens.

Incyte (INCY) Ownership

INCY price $122.30 +2.00 +1.66%

Ticker
INCY
Price
$122.30
Change
+2.00 +1.66%
Market cap
$24.93B
P/E
60.78
Forward P/E
15.47
Dividend yield
0.00%
Beta
0.78
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
51
Value
37
Quality
73
Growth
42

Stocklytics score rationale: value 37, quality 73, growth 42.

AI Score 65. Incyte Corporation has a market cap of $24.47 billion and a high price-to-earnings ratio of 57.16, indicating potential overvaluation. Despite strong gross profit margins of 92.69% and a solid current ratio of 3.84, the company has reported negative net income in recent quarters, which raises concerns about its profitability and growth sustainability

Insights · Forecast · Financials · Learn

Stocklytics home · Screener